GeminIQ Website Logo

Viewing BOLD free

Subscribe for full history, 50+ metrics, screener, watchlist...

Boundless Bio, Inc.

BOLD

Companies in Pharmaceutical Preparations

Boundless Bio, Inc. (BOLD) — SEC Financial Statements & Analysis

Boundless Bio, Inc. (BOLD) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
171815151527403125
Short Term Investments
759010311212312612714880
Prepaid Expense And Other Assets Current
223322347
Assets Current
95110120130140154170183112
Property Plant And Equipment Net
333444442
Operating Lease Right Of Use Asset
434444454647011
Restricted Cash Noncurrent
111111111
Other Assets
000000001
Assets
141157169179191206175188117
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accrued Liabilities Current
677655768
Employee Related Liabilities Current
132113321
Operating Lease Liability Current
33320-012
Liabilities Current
10131296810911
Operating Lease Liability Noncurrent
454647484848---
Liabilities
555859575556---
Temporary Equity Carrying Amount Attributable To P…
-----000248
Stockholders Equity
Preferred Stock Value
00000000-
Common Stock Value
000000000
Additional Paid In Capital
36035835735635435235034810
Accumulated Other Comprehensive Income Loss Net Of…
-000-0000-0-0
Retained Earnings Accumulated Deficit
-273-260-247-233-217-201-185-169-152
Stockholders Equity
8699110123137151165179-141
Liabilities And Stockholders Equity
141157169179191206175188117
Temporary Equity Par Or Stated Value Per Share
-----0000
Temporary Equity Liquidation Preference
--------252
Preferred Stock Par Or Stated Value Per Share
000000000
Preferred Stock Shares Authorized
707070707070707070
Temporary Equity Shares Authorized
-----000287
Preferred Stock Shares Issued
00000000-
Temporary Equity Shares Issued
-----000287
Temporary Equity Shares Outstanding
-----000287
Preferred Stock Shares Outstanding
00000000-
Common Stock Par Or Stated Value Per Share
000000000
Common Stock Shares Authorized
700700700700700700700700700
Common Stock Shares Issued
222222222222222223
Shares Outstanding
222222222222222220

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
20260.69%77.78%----------
2025-23.61%-29.86%-12.15%-5.08%-3.39%23.73%-7.14%-4.76%0.00%-5.26%37.72%27.19%
20241.05%-56.41%-66.60%8.68%10.42%3.47%-17.77%-23.19%-27.41%-5.96%9.27%-30.46%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
9.87
8.74
10.14
14.08
22.15
18.98
17.03
20.45
10.54
Quick Ratio
9.69
8.58
9.93
13.80
21.81
18.70
16.70
20.02
9.85
Working Capital
85.03M
97.07M
108.31M
120.48M
134.03M
146.26M
160.44M
174.18M
101.52M
Leverage & Debt
Debt to Equity
0.63
0.59
0.53
0.46
0.40
0.37
0.06
0.05
-0.08
Debt Ratio
0.39
0.37
0.35
0.32
0.29
0.27
0.06
0.05
0.09
Efficiency & Turnover
Asset Turnover TTM
0.00
0.00
0.00
0.00
0.00
0.00
-
-
-
Per Share Metrics
Diluted EPS TTM
-2.50
-2.60
-2.76
-2.88
-2.95
-3.85
-
-
-
Free Cash Flow Per Share TTM
-2.12
-2.11
-2.35
-2.52
-2.79
-3.73
-
-
-
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
-
-
-
Growth Metrics
Net Income Growth (1Y)
-14.76%
-10.96%
-
-
-
-
-
-
-
EPS Growth (1Y)
-15.17%
-32.37%
-
-
-
-
-
-
-
Valuation Metrics
P/E TTM
-0.44
-0.46
-0.45
-0.35
-0.51
-0.75
-
-
-
P/B
0.29
0.27
0.25
0.18
0.25
0.33
0.47
0.48
-2.03
Market Cap
24.65M
26.83M
27.53M
22.58M
33.67M
49.25M
77.22M
85.23M
286.82M
Enterprise Value
6.60M
8.40M
11.99M
7.88M
18.00M
22.11M
36.45M
53.31M
261.12M
Calculated Values
Free Cash Flow TTM
-47.60M
-47.21M
-52.71M
-56.24M
-62.11M
-63.38M
-
-
-
Net Debt
-18.04M
-18.43M
-15.54M
-14.70M
-15.68M
-27.15M
-40.77M
-31.92M
-25.70M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-06-29Purchase
Owner: Tang, Kevin, Tang Capital…
Title: -
Shares: 64,762
Price/Share: $2.48
Value: $160,609.76
Shares Owned: 2,533,845
Relationship: TenPercentOwner
Ownership: Indirect
2024-04-02Purchase
Owner: Burow, Kristina
Title: -
Shares: 200,000
Price/Share: $16.00
Value: $3,200,000.00
Shares Owned: 1,181,766
Relationship: Director,TenPercentOwner
Ownership: Indirect
2024-04-02Purchase
Owner: Kolchinsky, Peter, Shah R…
Title: -
Shares: 312,500
Price/Share: $16.00
Value: $5,000,000.00
Shares Owned: 1,884,787
Relationship: TenPercentOwner
Ownership: Indirect
2024-04-02Purchase
Owner: Arch, Venture Partners Ix…
Title: -
Shares: 200,000
Price/Share: $16.00
Value: $3,200,000.00
Shares Owned: 1,181,766
Relationship: TenPercentOwner
Ownership: Indirect
2024-04-02Purchase
Owner: Gillis, Steven, Nelsen Ro…
Title: -
Shares: 200,000
Price/Share: $16.00
Value: $3,200,000.00
Shares Owned: 1,181,766
Relationship: TenPercentOwner
Ownership: Indirect

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
37.38%
Inst. Shares: 8,376,328
Shares Outstanding: 22,407,000
2025-12-31
38.94%
Inst. Shares: 8,705,924
Shares Outstanding: 22,360,000
2025-09-30
42.92%
Inst. Shares: 9,607,585
Shares Outstanding: 22,386,000
2025-06-30
43.59%
Inst. Shares: 9,744,149
Shares Outstanding: 22,356,000
2025-03-31
58.07%
Inst. Shares: 12,950,088
Shares Outstanding: 22,300,000

Research Faster.
Invest Smarter.

Boundless Bio, Inc. (BOLD) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.